EYESW (Second Sight Medical Products) Piotroski F-Score: 3 (As of Jun. 29, 2026) — Near Median


What is Second Sight Medical Products Piotroski F-Score?

Second Sight Medical Products EYESW Piotroski F-Score is 3 as of Jun. 29, 2026, which is at its 10-year median of 3.00. The stock has 1 warning sign investors should review.

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Second Sight Medical Products has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Second Sight Medical Products's Piotroski F-Score or its related term are showing as below:

EYESW' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 3   Max: 6
Current: 3

During the past 10 years, the highest Piotroski F-Score of Second Sight Medical Products was 6. The lowest was 1. And the median was 3.

Second Sight Medical Products  (NAS:EYESW) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Second Sight Medical Products Piotroski F-Score Related Terms


Second Sight Medical Products Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Second Sight Medical Products's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Second Sight Medical Products Piotroski F-Score Chart

Second Sight Medical Products Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 3.00 3.00 1.00

Second Sight Medical Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 2.00 1.00 3.00 3.00

EYESW vs SONX, LUCD, LHDX: Piotroski F-Score Comparison

For the Medical Devices subindustry, Second Sight Medical Products's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Second Sight Medical Products Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Second Sight Medical Products's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Second Sight Medical Products's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun22) TTM:Last Year (Jun21) TTM:
Net Income was -2.501 + -1.283 + -2.212 + -3.076 = $-9.07 Mil.
Cash Flow from Operations was -1.8 + -2.425 + -1.975 + -3.222 = $-9.42 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0.13 + 0 + 0 = $0.13 Mil.
Average Total Assets from the begining of this year (Jun21)
to the end of this year (Jun22) was
(75.916 + 73.63 + 70.879 + 68.538 + 65.649) / 5 = $70.9224 Mil.
Total Assets at the begining of this year (Jun21) was $75.92 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $57.39 Mil.
Total Current Liabilities was $2.59 Mil.
Net Income was -1.603 + -1.291 + -2.843 + -2.294 = $-8.03 Mil.

Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0.5 + 0 + 0 = $0.50 Mil.
Average Total Assets from the begining of last year (Jun20)
to the end of last year (Jun21) was
(4.805 + 3.522 + 4.46 + 28.145 + 75.916) / 5 = $23.3696 Mil.
Total Assets at the begining of last year (Jun20) was $4.81 Mil.
Long-Term Debt & Capital Lease Obligation was $0.15 Mil.
Total Current Assets was $75.44 Mil.
Total Current Liabilities was $3.66 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Second Sight Medical Products's current Net Income (TTM) was -9.07. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Second Sight Medical Products's current Cash Flow from Operations (TTM) was -9.42. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun21)
=-9.072/75.916
=-0.1195005

ROA (Last Year)=Net Income/Total Assets (Jun20)
=-8.031/4.805
=-1.67138398

Second Sight Medical Products's return on assets of this year was -0.1195005. Second Sight Medical Products's return on assets of last year was -1.67138398. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Second Sight Medical Products's current Net Income (TTM) was -9.07. Second Sight Medical Products's current Cash Flow from Operations (TTM) was -9.42. ==> -9.42 <= -9.07 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun21 to Jun22
=0/70.9224
=0

Gearing (Last Year: Jun21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun20 to Jun21
=0.151/23.3696
=0.00646139

Second Sight Medical Products's gearing of this year was 0. Second Sight Medical Products's gearing of last year was 0.00646139. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun22)=Total Current Assets/Total Current Liabilities
=57.389/2.591
=22.14936318

Current Ratio (Last Year: Jun21)=Total Current Assets/Total Current Liabilities
=75.438/3.661
=20.6058454

Second Sight Medical Products's current ratio of this year was 22.14936318. Second Sight Medical Products's current ratio of last year was 20.6058454. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Second Sight Medical Products's number of shares in issue this year was 0. Second Sight Medical Products's number of shares in issue last year was 0. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.13/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.5/0
=

Second Sight Medical Products's gross margin of this year was . Second Sight Medical Products's gross margin of last year was . ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun21)
=0/75.916
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun20)
=0/4.805
=0

Second Sight Medical Products's asset turnover of this year was 0. Second Sight Medical Products's asset turnover of last year was 0. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+1+1+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Second Sight Medical Products has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 3 mean?
Second Sight Medical Products (EYESW) has a Piotroski F-Score of 3 as of Jun. 29, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Second Sight Medical Products and its competitors. This is near median its historical median of 3.00. Over the past decade, Second Sight Medical Products' Piotroski F-Score has ranged from 1.00 to 6.00.
Is Second Sight Medical Products' Piotroski F-Score too high?
Second Sight Medical Products' current Piotroski F-Score of 3 is near median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 6.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Second Sight Medical Products' value of 3 is 40% below this industry median.
How does Second Sight Medical Products' Piotroski F-Score compare to SONX and LUCD?
Second Sight Medical Products' Piotroski F-Score of 3 can be compared against companies in the Medical Devices & Instruments industry. The industry median Piotroski F-Score is 5.00. Second Sight Medical Products' value of 3 is 40% below this benchmark. Historically, Second Sight Medical Products' own Piotroski F-Score has ranged from 1.00 to 6.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 5.00, Second Sight Medical Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Second Sight Medical Products's current Piotroski F-Score of 3 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Second Sight Medical Products and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Second Sight Medical Products's current Piotroski F-Score is 3, which is near median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Second Sight Medical Products stock overvalued right now?
Second Sight Medical Products (EYESW) has a current Piotroski F-Score of 3. The current Piotroski F-Score is 3, which is near median its 10-year median of 3.00 and 40% below the Medical Devices & Instruments industry median of 5.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Second Sight Medical Products (EYESW), the current Piotroski F-Score is 3 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Second Sight Medical Products Business Description

Address 13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.